Rise of GLP-1 drugs brings substantial litigation risk: DAC Beachcroft
Reinsurance News - Dec 18, 2025
Law firm DAC Beachcroft warns of surging product liability claims that come with the rise of popular Glucagon-like peptide-1 receptor agonists (or GLP-1s), drugs for obesity management. While drugs like Ozempic and Wegowy offer health benefits, their rapid adoption has sparked a wave of legal challe...
Recommended Articles
Posted: Mar 27, 2026
The data centre industry is evolving into increasingly complex, high-energy-density facilities that...
Posted: Mar 27, 2026
XS Global, an independently owned managing general underwriting (MGU) platform, has announced the ap...
Posted: Mar 27, 2026
The Southeast Asia Disaster Risk Insurance Facility (SEADRIF) Insurance Company, a regional initiati...